Social Cognitive Assessment in Autism and Schizophrenia

NCT ID: NCT02660775

Last Updated: 2022-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

440 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-12-04

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In people with schizophrenia or people with autism, impairments of social cognition are a core feature of the disease and, according to researchers who represent valuable references on this subject for the international community, three to five processes of social cognition are usually altered in those diseases: (1) emotional processing which is the ability to identify emotions through facial expressions, gestures, and tone of voice, (2) theory of mind (ToM), which is defined as "the ability to attribute mental states (beliefs, intents, desires, …) to oneself and others, and to understand that others have beliefs, intentions, and desires that are different from one's own", (3) attributional style which refers to how people explain the causes of positive and negative events, and corresponding, in schizophrenia, to self-serving and personalizing bias that means a tendency to blame others for negative life events rather than sharing the responsibilities between different sources; and (4 and 5) social perception and knowledge, which can be defined as decoding and interpreting social cues from others, taking the social context into account, and knowing social rules, roles, and goals. Components of social cognition appear to be related to both symptomatology and functioning in everyday life. The present study aims to assess a new social cognitive battery developed by several teams in France: ClaCoS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The project's objectives are: (1) to assess relevance of ClaCoS in schizophrenia and autism compared to healthy controls, and to analyze links between social cognition and both neurocognition and symptoms, (2) to collect data in a large sample of healthy controls in order to establish appropriate standards for tools composing ClaCoS battery.

For the first objective, three kind of evaluation will be proposed: clinical, neurocognitive and social cognitive (ClaCoS). Three populations of 80 participants will be compared: healthy controls, patients with schizophrenia or schizoaffective disorders, and patients with autism spectrum disorders. These three groups will be matched on sex, age and level of education.

For the second objective a systematic collection of data will be carried out in a large sample of healthy controls. In this part of the study, only social cognitive measures will be recorded. Subjects will be ranked according to three criteria: three classes for age (18-25 years old, 26-35 and 36-45), five classes for socio-professional status according to the INSEE classification, and two classes for sex (men/women).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

schizophrenia

this project is to assess relevance of ClaCoS in schizophrenia compared to healthy controls, and to analyze links between social cognition and both neurocognition and symptoms, (2) to collect data in a large sample of healthy controls in order to establish appropriate standards for tools composing ClaCoS battery.

Group Type EXPERIMENTAL

schizophrenia

Intervention Type BEHAVIORAL

The battery (ClaCoS) is composed by 6 tests and several scores will be recorded for each:

* for emotion perception : Facial emotions recognition task (TREF)
* for theory of mind : Movie for the assessment of social cognition ( MASC-VF)
* for attributional bias : Ambiguous Intentions Hostility Questionnaire ( AIHQ)
* for social perception and knowledge : interpretation score - with and without index, comprehension score ( PerSo )
* for empathy :Questionnaire of cognitive and affective empathy ( QCAE) for people with schizophrenia
* for self assessment : Self - assessment of social cognition (ACSo)

autism

this project is to assess relevance of ClaCoS in autism compared to healthy controls, and to analyze links between social cognition and both neurocognition and symptoms, (2) to collect data in a large sample of healthy controls in order to establish appropriate standards for tools composing ClaCoS battery.

Group Type EXPERIMENTAL

Autism

Intervention Type BEHAVIORAL

The battery (ClaCoS ) is composed by 6 tests and several scores will be recorded for each:

* for emotion perception : Facial emotions recognition task(TREF ): total score, score per emotion, detection levels
* for theory of mind : Movie for the assessment of social cognition (MASC ) :total score, error type
* for attributional bias : Ambiguous Intentions Hostility Questionnaire (AIHQ) :hostility score, attribution score, aggression score
* for social perception and knowledge : interpretation score - with and without index, comprehension score ( PerSo )
* for empathy : Empathy quotient (EQ)
* for self assessment : Self - assessment of social cognition ( ACSo ): total score and scores per processes

healthy controls

this project is to assess relevance of ClaCoS in autism compared to healthy controls, and to analyze links between social cognition and both neurocognition and symptoms, (2) to collect data in a large sample of healthy controls in order to establish appropriate standards for tools composing ClaCoS battery.

Group Type PLACEBO_COMPARATOR

Healthy controls

Intervention Type BEHAVIORAL

only social cognitive measures

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

schizophrenia

The battery (ClaCoS) is composed by 6 tests and several scores will be recorded for each:

* for emotion perception : Facial emotions recognition task (TREF)
* for theory of mind : Movie for the assessment of social cognition ( MASC-VF)
* for attributional bias : Ambiguous Intentions Hostility Questionnaire ( AIHQ)
* for social perception and knowledge : interpretation score - with and without index, comprehension score ( PerSo )
* for empathy :Questionnaire of cognitive and affective empathy ( QCAE) for people with schizophrenia
* for self assessment : Self - assessment of social cognition (ACSo)

Intervention Type BEHAVIORAL

Autism

The battery (ClaCoS ) is composed by 6 tests and several scores will be recorded for each:

* for emotion perception : Facial emotions recognition task(TREF ): total score, score per emotion, detection levels
* for theory of mind : Movie for the assessment of social cognition (MASC ) :total score, error type
* for attributional bias : Ambiguous Intentions Hostility Questionnaire (AIHQ) :hostility score, attribution score, aggression score
* for social perception and knowledge : interpretation score - with and without index, comprehension score ( PerSo )
* for empathy : Empathy quotient (EQ)
* for self assessment : Self - assessment of social cognition ( ACSo ): total score and scores per processes

Intervention Type BEHAVIORAL

Healthy controls

only social cognitive measures

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18-45 years old
* No psychiatric or neurologic conditions or comorbidity
* No relatives with people with people with history of neuropsychiatric disease
* French native language or education in a French school since the first year of primary school
* Consent to participate to the study

Exclusion Criteria

* Aged 18-45 years old
* Patients with schizophrenia: diagnosis assessed with DSM5 criteria
* No modification of psychotropic treatment during the month before inclusion
* French native language or education in a French school since the first year of primary school
* Consent to participate to the study and agreement of the legal guardian
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hôpital le Vinatier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

FRANCK NICOLAS, PUPH

Role: PRINCIPAL_INVESTIGATOR

Service Universitaire de Réhabilitation - Le Vinatier Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Professeur FRANCK Nicolas

Bron, Auvergne-Rhône-Alpes, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-A00580-49

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Social Cognition Intervention
NCT01267019 COMPLETED NA